Our in vivo results suggested that anti TNF-α Ab, infliximab could inhibit mast cell accumulation in the colon, resulting in decreased levels of TNF-α and attenuated colon cancer in AOM/DSS mice. This evidence concerns the gene TNF and colonic neoplasm.